共 50 条
- [34] FAILURE OF BACILLUS CALMETTE-GUERIN THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER: DEFINITION AND TREATMENT OPTIONS [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2016, 69 (07): : 423 - 433
- [35] DIABETES SEVERITY AND METFORMIN ARE ASSOCIATED WITH INTRAVESICAL BACILLUS CALMETTE-GUERIN OUTCOMES IN NON MUSCLE INVASIVE BLADDER CANCER [J]. JOURNAL OF UROLOGY, 2019, 201 (04): : E229 - E229
- [36] A MULTI-INSTITUTIONAL ANALYSIS OF PATIENT OUTCOMES FOLLOWING INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR NON-MUSCLE INVASIVE BLADDER CANCER [J]. JOURNAL OF UROLOGY, 2010, 183 (04): : E524 - E524
- [39] INTRAVESICAL GEMCITABINE VERSUS BACILLUS CALMETTE-GUERIN (BCG) IN TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER: SHORT TERM COMPARATIVE STUDY [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E664 - E665
- [40] Effects of intravesical therapy with platelet-rich plasma (PRP) and Bacillus Calmette-Guerin (BCG) in non-muscle invasive bladder cancer [J]. TISSUE & CELL, 2018, 52 : 17 - 27